C8 Medisensors Gains CE Mark Approval for The
C8 Medisensors Optical Glucose Monitor ™ System
For People with Diabetes
A New Non-Invasive Continuous Glycose Monitor is approved for marketing in Europe
Dear,
We are pleased to contact you with ur latest news: c8 medisensors, inc. have reirized
CE Mark Approval for ITS Optical Glucose Monitor System.Our New Non-Invasive Continuous Glucose Monitor (NCGM), Will Be Marketed in Europe.
The Comprehensive, 10-YEAR DIABETES CONTROL AND COMPLICATIONS Trial (DCCT) Clearly Demonstated that individuals with type 1 diabetes Who Kept Blood Glucose Levels As Close To Normal As Possible For As Possible Had Less Chance of Developing Disease-Relate Complications.The DCCT Found That the Risk of Eye Disease was reduced by 76%, Kidney Disease by 50%and Nerve Disease by 60%. [1]Since that time, other studies have confirmed the importance of tight glycamic control with minimal glucose excursions in reducing desaase-related complications not only in type 1 diabetes, but also in Type 2. [2-6]
In Addition, A Large Number of Studies have shown that continuous Glucose monitor (CGM) Can Improve Glycamic Control With Reded Risk of Hypoglycaiamia. [7-19] CGMS Are Adjunct Devices That Are intended to complement Finger Sick Blood Blood Glucose Tests.Traditional CGMS RELY ON A NEEDLE SENSOR INSERTED Under The Skin, which can cause pain or discomfort, and possesses Risk of infection. [20]In contrast, The C8 Medisensors Optical Glucose Monitor System Harnesses The Power of Light to Measure Glucose Levels.Using Raman Spectroscopy, Beam of Light Is Shone into the Skin and the Result Vibrates of Glucose Molecules are Measured to Give A Glucose Reading;End Achieved via Small, Pain-Free Portable Monitor, Discreetly Worn Under Clothes Against The Skin.
For Added Convenience tohe Readings Are Stored and Sent Wirelessly to the User’s Smartphone for Glucose Readings at A Glance, providing the Wearer with a Continuous Picture of Glucose Dynamics Thour The Day.A Good Underestanding of Glucose Levels is invaluable in managing diabetes and improving patient outcomes. [1]In Clinical Studies, The C8 Medisensors Monitor was Found to have comparable to Earlier Versions of Invasive Cgms When Those Systems were First Introduced, But with Less Pain and Less Risk of Infection.
“C8 Medisensors was co-footed by a Father Trying to Help His are Living With Diabetes, and As A Company, We Remain Dedicated To Helping Thue With The Disease,” Said Paul Zygielbaum, CEO of C8 Medisensors.“CE Mark Approval is a Landmark Step for This Unique Technology.OUR TEAM IS HUGHELY EXCITED TO BE WORKING TO MAKE NCGM AND THE OPTICAL GLUCOSE MONITOR SYSTEM AVAILABLE THRUOUT Europe. ”
The C8 Medisensors Optical Glucose Monitor System is not yet Shipping But Will Soon Be Available For Purchase Online Via The C8 Medisensors Website, www.c8medisensors.com .
The C8 Medisensors Optical Glucose Monitor System Is An Adjunct Device.It is contraindicated in pregnancy and forys under 18 Years of Age, as well as in individuals with very light or see Dark Skin Tones, Peripheral Vascular Disease Or Individuals Who Smoke.